Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Tabletop Fire Pit Lawsuit Individuals who suffered severe burns, or families who lost a loved one in a tabletop fire pit explosion, may be eligible for financial compensation through a fire pit injury lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Dupixent Lawsuit Dupixent lawsuits are being investigated for patients who developed rare blood cancers such as cutaneous T-cell lymphoma (CTCL) after receiving injections, alleging that Sanofi and Regeneron failed to warn about the potential risks of immune suppression and delayed cancer diagnosis.
Ocaliva Lawsuit Ocaliva lawsuits are being investigated for users who experienced liver failure, cirrhosis progression, transplant, or death after taking the drug, alleging that Intercept Pharmaceuticals failed to warn about the risk of dosing toxicity and accelerated liver damage.
Roblox Lawsuit Families are filing Roblox lawsuits after children were targeted by predators for grooming, sextortion, sexual abuse, or exploitation on the platform. Learn who qualifies, what cases allege, and how to file a confidential claim.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Synthetic Weed Linked to Nearly 100 Reports of Bleeding Problems, Two Deaths April 9, 2018 Irvin Jackson Add Your Comments Federal and state health officials warn that there have been reports of severe and sometimes deadly bleeding problems following the use of synthetic cannabis or weed, which may be sold under names like Spice, K2, AK47, Black Mamba, Kush and Kronic. The U.S. Centers for Disease Control and Prevention (CDC) issued an outbreak alert on April 5, indicating it has received at least 94 reports of synthetic weed bleeding problems from five different states over the past month, including at least two individuals who died. Indiana has seen the bulk of the synthetic weed bleeding cases, with 89 incidents, including both deaths. There have also been two reports from Indiana, and one from Maryland, Missouri and Wisconsin each. All of the reports indicated individuals were admitted to emergency rooms with serious, unexplained bleeding. Do You Know about… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Do You Know About… SPORTS BETTING ADDICTION LAWSUITS FOR YOUNG ADULTS Gambling addiction and severe financial losses have been linked to popular sports betting platforms like DraftKings, FanDuel, and Caesars. Lawsuits are being filed by young adults and students who were targeted by deceptive promotions, addictive app features, and aggressive marketing tactics. See if you qualify for a sports betting addiction lawsuit. Learn More SEE IF YOU QUALIFY FOR COMPENSATION The day after the CDC warning, the Illinois Department of Public Health issued its own warning, indicating that it has now received reports of 95 cases statewide. According to the CDC, none of the patients were on blood thinners. However, they responded to treatments involving fresh frozen plasma and high doses of vitamin K; similar to how doctors treat bleeding events from the rat poison, brodifacoum, or the blood thinner Coumadin (warfarin). This is a sign that they were suffering from long-acting vitamin k-dependent antagonist toxicity. Laboratory investigations have confirmed brodifacoum exposure in at least 18 patients; all of whom reported using synthetic cannabis. An analysis of at least three of the product samples linked to the outbreak have tested positive for brodifacoum, suggesting these products are being laced with rat poison. Signs of long-acting vitamin k-dependent antagonist toxicity and bleeding include: Bruising Nosebleeds Bleeding gums Disproportionate bleeding from injuries Vomiting blood Coughing up blood Bloody urine or stool Excessively heavy menstrual bleeding Back or flank pain Altered mental status Fainting, collapsing, or loss of consciousness “These chemicals are called cannabinoids because they are similar to chemicals found in the marijuana plant. Because of this similarity, synthetic cannabinoids are sometimes misleadingly called ‘synthetic marijuana’ (or ‘fake weed’), and they are often marketed as safe, legal alternatives to that drug,” Indiana health officials warned in their press release. “In fact, they are not safe and may affect the brain much more powerfully than marijuana; their actual effects can be unpredictable and, in some cases, more dangerous or even life-threatening.” The CDC is warning emergency rooms to advise victims of the outbreak not to use synthetic cannabis due to the risk of future contamination. The CDC also indicates that the outbreak may be straining some hospitals’ supplies of vitamin K, warning that patients may need to be treated for months, at a cost of about $8,000 for two weeks of treatment. Additionally, at least three patients in Illinois donated plasma before their bleeding events, and the CDC and FDA are looking into the possible effects of this, and have added questions about plasma and blood donations to questionnaires being given out to other victims. The CDC is warning healthcare providers, particularly those in Illinois and neighboring states, to be alert for vitamin K-dependant antagonist coagulopathy in patients with excessive bleeding unrelated to an injury or without another explanation. Some may divulge their use of synthetic cannabis products, while others may not. These patients should have their coagulation profile checked. Health care providers are also urged to contact their local poison information center by calling 1-800-222-1222 for questions on diagnostic testing and management of these patients. Future incidents, or similar incidents that occurred since February 1, should also be reported to local or state health departments. Written by: Irvin Jackson Senior Legal Journalist & Contributing Editor Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends. Tags: Bleeding, Coumadin, Drug Abuse, Illinois, Marijuana, Poison, Synthetic Cannabis, Warfarin More Lawsuit Stories Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects November 26, 2025 Six Bard PowerPort Lawsuits Will Go Before Juries Between May 2026 and Feb. 2027 November 26, 2025 Walmart Christmas Lights Lawsuit Alleges ‘Holiday Time’ LED Bulbs Overheated, Caused Fire November 26, 2025 0 Comments EmailThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA Term Δ MORE TOP STORIES Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025) Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025) Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)
Walmart Christmas Lights Lawsuit Alleges ‘Holiday Time’ LED Bulbs Overheated, Caused Fire November 26, 2025
Sudden Ozempic Blindness Reports Raise Concerns Over NAION Side Effects (Posted: yesterday) An increasing number of Ozempic and Mounjaro users are reporting sudden, irreversible vision loss from NAION side effects, prompting new lawsuits and a federal push to consolidate blindness claims into a dedicated multidistrict litigation. MORE ABOUT: OZEMPIC LAWSUITOzempic, Similar Drugs Linked to Higher Risk of GI Side Effects: Study (11/21/2025)Lawsuits Over Ozempic Vision Loss and Gastrointestinal Injuries Will Be Separately Managed in NJ State Court (11/17/2025)Judge Extends Deadlines To Address GLP-1 Lawsuit ‘Cross-Cutting’ Issues (10/28/2025)
Ongoing Cartiva Lawsuit Settlement Negotiations Cited as Reason to Reject MDL Consolidation (Posted: 2 days ago) Cartiva is urging federal judges to reject consolidation of toe-implant lawsuits, arguing that an MDL would interfere with individual claim resolutions that the company says are already being handled efficiently outside of court. MORE ABOUT: CARTIVA IMPLANT LAWSUITCartiva Lawsuits Allege Toe Implant Fails in About 64% of Patients (11/12/2025)MDL Sought for Cartiva Implant Lawsuits Filed in Federal Court System (11/03/2025)Lawsuit Claims Cartiva SCI Failure Caused by Defective Design of Big Toe Implant (09/18/2025)
Covidien Symbotex Mesh Lawsuit Reset For Trial in July 2026 (Posted: 3 days ago) The first Covidien Symbotex mesh bellwether has been restored to the 2026 trial calendar, signaling renewed momentum in a litigation where more than 2,000 similar claims are still awaiting resolution. MORE ABOUT: HERNIA MESH LAWSUITFeb. 2026 Trial for Covidien Hernia Mesh Lawsuit Canceled by MDL Judge (11/05/2025)Covidien Seeks Dismissal of Lawsuits Over Hernia Mesh Complications (09/08/2025)Deadline for Covidien Mesh Settlement Negotiations Extended Until Jan. 2026 (08/21/2025)